EDITION
2024

Back to the 2024 edition

Summary - 2024 Edition

2024
Sponsors
Previous
Next
barre orange 2024 - edition
2024
Participants
arrondi2 2024 - edition
1BU 2 INNOVATION R&D
2-OBSERVE
3C3D
AALBORG UNIVERSITY HOSPITAL
ABISS – ANALYTIC BIOSURGICAL SOLUTIONS
ABSISKEY
ACCSIS SANTE CAE ELYCOOP
ACIES
AD SCIENTIAM
ADALYS
ADAMAS
ADN AXDANE
ADVICENNE
AEPI GRENOBLE
AERI
AGUETTANT
ALERE
ALFRED MAHN FOUNDATION – TECHNION
ALSACE BIOVALLEY
AMNIS THERAPEUTICS
ANACONDA BIOMED
ANATOSCOPE
ANGELS SANTE
ARAYMONDLIFE
ARD FRANCHE CONTE
1BU 2 INNOVATION R&D
2-OBSERVE
3C3D
AALBORG UNIVERSITY HOSPITAL
ABISS – ANALYTIC BIOSURGICAL SOLUTIONS
ABSISKEY
ACCSIS SANTE CAE ELYCOOP
ACIES
AD SCIENTIAM
ADALYS
ADAMAS
ADN AXDANE
ADVICENNE
AEPI GRENOBLE
AERI
AGUETTANT
ALERE
ALFRED MAHN FOUNDATION – TECHNION
ALSACE BIOVALLEY
AMNIS THERAPEUTICS
ANACONDA BIOMED
ANATOSCOPE
ANGELS SANTE
ARAYMONDLIFE
ARD FRANCHE CONTE
1BU 2 INNOVATION R&D
2-OBSERVE
3C3D
AALBORG UNIVERSITY HOSPITAL
ABISS – ANALYTIC BIOSURGICAL SOLUTIONS
ABSISKEY
ACCSIS SANTE CAE ELYCOOP
ACIES
AD SCIENTIAM
ADALYS
ADAMAS
ADN AXDANE
ADVICENNE
AEPI GRENOBLE
AERI
AGUETTANT
ALERE
ALFRED MAHN FOUNDATION – TECHNION
ALSACE BIOVALLEY
AMNIS THERAPEUTICS
ANACONDA BIOMED
ANATOSCOPE
ANGELS SANTE
ARAYMONDLIFE
ARD FRANCHE CONTE
1BU 2 INNOVATION R&D
2-OBSERVE
3C3D
AALBORG UNIVERSITY HOSPITAL
ABISS – ANALYTIC BIOSURGICAL SOLUTIONS
ABSISKEY
ACCSIS SANTE CAE ELYCOOP
ACIES
AD SCIENTIAM
ADALYS
ADAMAS
ADN AXDANE
ADVICENNE
AEPI GRENOBLE
AERI
AGUETTANT
ALERE
ALFRED MAHN FOUNDATION – TECHNION
ALSACE BIOVALLEY
AMNIS THERAPEUTICS
ANACONDA BIOMED
ANATOSCOPE
ANGELS SANTE
ARAYMONDLIFE
ARD FRANCHE CONTE
1BU 2 INNOVATION R&D
2-OBSERVE
3C3D
AALBORG UNIVERSITY HOSPITAL
ABISS – ANALYTIC BIOSURGICAL SOLUTIONS
ABSISKEY
ACCSIS SANTE CAE ELYCOOP
ACIES
AD SCIENTIAM
ADALYS
ADAMAS
ADN AXDANE
ADVICENNE
AEPI GRENOBLE
AERI
AGUETTANT
ALERE
ALFRED MAHN FOUNDATION – TECHNION
ALSACE BIOVALLEY
AMNIS THERAPEUTICS
ANACONDA BIOMED
ANATOSCOPE
ANGELS SANTE
ARAYMONDLIFE
ARD FRANCHE CONTE
1BU 2 INNOVATION R&D
2-OBSERVE
3C3D
AALBORG UNIVERSITY HOSPITAL
ABISS – ANALYTIC BIOSURGICAL SOLUTIONS
ABSISKEY
ACCSIS SANTE CAE ELYCOOP
ACIES
AD SCIENTIAM
ADALYS
ADAMAS
ADN AXDANE
ADVICENNE
AEPI GRENOBLE
AERI
AGUETTANT
ALERE
ALFRED MAHN FOUNDATION – TECHNION
ALSACE BIOVALLEY
AMNIS THERAPEUTICS
ANACONDA BIOMED
ANATOSCOPE
ANGELS SANTE
ARAYMONDLIFE
ARD FRANCHE CONTE
2024
Conference Programme

PLENARY SESSION

Tuesday, December 3rd, 2024

As hospitals evolve in response to technological advancements and patient-centric demands, stakeholders must align to maximize benefits and overcome challenges for patients, clinicians and healthcare innovators. This spotlight session will focus on these critical shifts and how to strengthen collaborative models to ensure value creation.

How are technological advancements reshaping traditional hospital models, and what are the implications for patient care and MedTech innovation? What collaborative approaches between hospitals and MedTech companies optimise value creation for healthcare delivery and patient outcomes? What are the successful examples of lasting industry and healthcare professionals’ collaborations and what is the impact on innovation development and patients? What economic challenges do hospitals face in adopting new MedTech, and how can companies contribute to cost-effective healthcare? How does digitisation impact hospital operations, and what opportunities does it present for integrating MedTech solutions like AI, robotics, and AR? What opportunities and challenges arise when extending MedTech solutions beyond hospital settings, such as community care and home healthcare? How to further leverage hospital and patient data to fuel innovation?

Aenean sodales diam vitae felis euismod maximus. Aliquam non justo nulla. Integer orci turpis, ultrices sed rhoncus a, porttitor nec lectus. Maecenas non consectetur nisl. Nunc eget vestibulum mi. Cras interdum dictum urna sed blandit. Aenean porta elit rutrum libero eleifend efficitur. Donec vitae semper nisi. Fusce at dolor elit. Sed feugiat tincidunt lorem at fringilla.

Tuesday, December 3rd, 2024

Keynote speakers and topics to announced.

Wednesday, December 4th, 2024

Keynote speakers and topics to announced.

Aenean sodales diam vitae felis euismod maximus. Aliquam non justo nulla. Integer orci turpis, ultrices sed rhoncus a, porttitor nec lectus. Maecenas non consectetur nisl. Nunc eget vestibulum mi. Cras interdum dictum urna sed blandit. Aenean porta elit rutrum libero eleifend efficitur. Donec vitae semper nisi. Fusce at dolor elit. Sed feugiat tincidunt lorem at fringilla.

Tuesday, December 3rd, 2024

Preventive healthcare has the potential to generate economic benefits and improve long-term health outcomes, but developing effective business models presents unique challenges. How can the economic benefits of investing in preventive healthcare be quantified? How to access and leverage the right data?  Will EHDS implementation be a game-changer for innovative companies?  What challenges do innovators face in designing reimbursement strategies for preventive digital health solutions? What examples of successful business models exist, and what lessons can be learned from their implementation? How to scale preventive digital health innovations effectively?

Wednesday, December 4th, 2024

Despite the potential of digital health and innovative therapies to revolutionize healthcare, adoption and development remain complex challenges. What is the current state of the regulatory and reimbursement pathways for digital health and medicine? What to expect from the EHDS? What initiatives are underway to promote interoperability, data sharing and access to secondary use of health data? Have reimbursement processes like DiGA or PECAN proved their effectiveness in deploying digital health solutions? What are the key components of successful value proposition and revenue model for digital health innovations? How do investment strategies of VCs and big players influence the development and adoption of digital health technologies? How can further collaboration between healthcare providers, regulators, industry, and patients accelerate their adoption?

Wednesday, December 4th, 2024

Augmented intelligence has the potential to enhance diagnostic decision-making in healthcare, but striking the right balance between human expertise and AI is crucial. How do clinicians work with AI systems in diagnostic decision-making, and what are the implications for patient care? What are the current training and education programmes available to equip clinicians with the skills and knowledge needed? What measures can be taken to ensure transparency and explainability of AI algorithms for both clinicians and patients? What ethical considerations arise when integrating AI into clinical practice? What lessons can be learned from successful implementations of AI in diagnostic decision-making?

Aenean sodales diam vitae felis euismod maximus. Aliquam non justo nulla. Integer orci turpis, ultrices sed rhoncus a, porttitor nec lectus. Maecenas non consectetur nisl. Nunc eget vestibulum mi. Cras interdum dictum urna sed blandit. Aenean porta elit rutrum libero eleifend efficitur. Donec vitae semper nisi. Fusce at dolor elit. Sed feugiat tincidunt lorem at fringilla.

Wednesday, December 4th, 2024

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam finibus, enim pellentesque volutpat porttitor, libero tellus tincidunt elit, ut vehicula diam mauris rutrum leo. Morbi in lacus a nisl tempus lacinia vitae sit amet magna. Suspendisse augue nibh, interdum sed quam eu, porttitor suscipit mauris. Nulla facilisi. Ut quis arcu vel nisi lobortis tincidunt. Sed porta, ligula vitae consequat efficitur, eros magna gravida lacus, et finibus lectus ligula in lorem.

Aenean congue tincidunt neque, nec ornare purus ultrices ac. Integer ultricies magna vitae nibh porttitor, in sagittis ipsum aliquet.

Aenean sodales diam vitae felis euismod maximus. Aliquam non justo nulla. Integer orci turpis, ultrices sed rhoncus a, porttitor nec lectus. Maecenas non consectetur nisl. Nunc eget vestibulum mi. Cras interdum dictum urna sed blandit. Aenean porta elit rutrum libero eleifend efficitur. Donec vitae semper nisi. Fusce at dolor elit. Sed feugiat tincidunt lorem at fringilla.

Tuesday, December 3rd, 2024

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam finibus, enim pellentesque volutpat porttitor, libero tellus tincidunt elit, ut vehicula diam mauris rutrum leo. Morbi in lacus a nisl tempus lacinia vitae sit amet magna. Suspendisse augue nibh, interdum sed quam eu, porttitor suscipit mauris. Nulla facilisi. Ut quis arcu vel nisi lobortis tincidunt. Sed porta, ligula vitae consequat efficitur, eros magna gravida lacus, et finibus lectus ligula in lorem.

Aenean congue tincidunt neque, nec ornare purus ultrices ac. Integer ultricies magna vitae nibh porttitor, in sagittis ipsum aliquet.

Aenean sodales diam vitae felis euismod maximus. Aliquam non justo nulla. Integer orci turpis, ultrices sed rhoncus a, porttitor nec lectus. Maecenas non consectetur nisl. Nunc eget vestibulum mi. Cras interdum dictum urna sed blandit. Aenean porta elit rutrum libero eleifend efficitur. Donec vitae semper nisi. Fusce at dolor elit. Sed feugiat tincidunt lorem at fringilla.

Wednesday, December 4th, 2024

For emerging startups in the healthcare industry, the journey to success begins with effective leadership. This session will feature MedTech and Biotech CEOs, sharing their journey and insights for aspiring founders seeking to navigate the challenges of startup leadership.

What are the essential qualities and skills for effective startup leadership? How to ensure founders are “business ready”, especially when coming from academia? How to build the right team that will convince investors? How to work with your board and as them as proper advisors? What are the strategies for attracting and retaining top talents?

2024
Speakers
Previous
Next
2024
Exhibitors
Previous
Next
2024
Pitchers
PITCH Theme

Search form

Keep up to date with the latest news from MEDigIT!

Monthly newsletter

"*" indicates required fields

Fullname*
This field is for validation purposes and should be left unchanged.

Early Bird rate

Until July 4th, 2024